Research LettersRisk factors for recurrence of primary sclerosing cholangitis of liver allograft
References (5)
- et al.
Homing of mucosal lymphocytes to the liver in the pathogenesis of hepatic complications of inflammatory bowel disease
Lancet
(2002) - et al.
Primary sclerosing cholangitis. Semin Gastrointestin
Dis
(2001)
There are more references available in the full text version of this article.
Cited by (201)
Gut-liver axis: Pathophysiological concepts and medical perspective in chronic liver diseases
2024, Seminars in ImmunologyPost-Transplant Immunosuppression in Autoimmune Liver Disease
2023, Journal of Clinical and Experimental HepatologyTransplantation Pathology
2023, MacSween's Pathology of the Liver, Eighth EditionDe novo and recurrent liver disease
2020, Best Practice and Research: Clinical GastroenterologyCitation Excerpt :Some studies have shown colectomy pre-LT reduces the incidence of rPSC [56], but this observation was not confirmed in a larger, multicenter study [55]. Multiple risk factors for rPSC have been identified including extremes of age at the time of LT, male gender, presence of cholangiocarcinoma, gender mismatch, cytomegalovirus (CMV) mismatch, or living-related donors (especially from parents) [57–62] (Table 1). Because numerous post-LT complications can cause biliary strictures, the diagnosis of rPSC can be challenging.
Copyright © 2002 Elsevier Ltd. All rights reserved.